Influence of catechol-O-methyltransferase polymorphism on entacapone efficacy in Parkinson's disease
Phase of Trial: Phase IV
Latest Information Update: 04 May 2010
At a glance
- Drugs Entacapone (Primary) ; Levodopa (Primary)
- Indications Parkinson's disease
- Focus Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 04 May 2010 Actual patient number (60) added as reported by ClinicalTrials.gov.
- 04 May 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.